All
RSSArticles
-
Study Investigates Reasons Why People Do Not Enroll in Clinical Trials
The study found that a main reason why so few people participate is because there is no trial for more than half of cancer patients for their particular type and stage of cancer.
-
Expedited Review Worksheet Includes 111-Criteria Checklist
The IRB at Central Michigan University revised its IRB application to make it more efficient and more closely aligned with federal regulations under 45 CFR § 46.111.
-
Remember IRB Review Criteria When Updating Application Design
A revised application served as an educational tool for researchers, and it helped reviewers focus on the 111 criteria and avoid bringing extraneous questions into their review.
-
New CDC TB Guidelines Will Emphasize Blood Tests
Workflow may get a little smoother for infection preventionists who also wear an occupational health hat. The CDC is expected to soon issue new tuberculosis testing guidelines for healthcare workers that will end routine annual TB screening in favor of a baseline test on hire and retesting after an occupational exposure. -
IPs Prepare for Ebola as Outbreak in Africa Continues
As an Ebola outbreak continues in the Democratic Republic of Congo, infection preventionists again face the threat of an ill traveler from the region walking through the doors of their EDs. -
Central and Local IRBs: Can This Marriage Be Saved?
As the new normal becomes single IRB review for multisite studies, some researchers are wary that this system may undermine the vital role of local IRBs to protect research subjects in their community.
-
Once in Retreat, MRSA Makes a Stand
The CDC is no longer on track to meet the 2020 goal of a 50% reduction in hospital-onset MRSA bloodstream infections from the 2015 baseline. -
Gene Therapy Studies on the Rise Due to Market Demands
The market’s growth raises the prospect of IRBs overseeing gene therapy clinical trials. It also means that research organizations, both large and small, should be prepared for such trials and develop or have access to an institutional biosafety committee.
-
Vaccines: We Forget the Past, Risk Repeating It
"The antivaccine sentiment is so deeply rooted. In my experience, and also in talking to my colleagues, it is very difficult to change the mindset of people who are intensely antivaccine."
-
HEAL: An NIH Moonshot Against Addiction and Pain
The National Institutes of Health is taking up this formidable research challenge with $850 million in federal funding, leveraging expertise from a wide variety of centers and institutes for the HEAL (Helping to End Addiction Long-term) initiative.